Evidence map›Paper›PMID 18337697›Full record

ArticleJournal of microbiology (Seoul, Korea)2008

The mutation of a novel Saccharomyces cerevisiae SRL4 gene rescues the lethality of rad53 and lcd1 mutations by modulating dNTP levels.

Do-Hee Choi, Young-Mi Oh, Sung-Hun Kwon, Sung-Ho Bae

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of microbiology (Seoul, Korea), 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Do-Hee ChoiDepartment of Biological Sciences, College of Natural Science, Inha University, Incheon 402-751, Republic of Korea.
Young-Mi Oh
Sung-Hun Kwon
Sung-Ho Bae
Inha University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The SRL4 (YPL033C) gene was initially identified by the screening of Saccharomyces cerevisiae genes that play a role in DNA metabolism and/or genome stability using the SOS system of Escherichia coli. In this study, we found that the srl4Delta mutant cells were resistant to the chemicals that inhibit nucleotide metabolism and evidenced higher dNTP levels than were observed in the wild-type cells in the presence of hydroxyurea. The mutant cells also showed a significantly faster growth rate and higher dNTP levels at low temperature (16 degrees C) than were observed in the wild-type cells, whereas we detected no differences in the growth rate at 30 degrees C. Furthermore, srl4Delta was shown to suppress the lethality of mutations of the essential S phase checkpoint genes, RAD53 and LCD1. These results indicate that SRL4 may be involved in the regulation of dNTP production by its function as a negative regulator of ribonucleotide reductase.

Indexed as

MutationAdaptor Proteins, Signal TransducingAmino Acid SequenceCell Cycle ProteinsCheckpoint Kinase 2Cold TemperatureDeoxyribonucleotidesDNA DamageGene Expression Regulation, FungalHydroxyureaMolecular Sequence DataNucleic Acid Synthesis InhibitorsPhosphoproteinsProtein Serine-Threonine KinasesRibonucleotide ReductasesSaccharomyces cerevisiaeAdaptor Proteins, Signal TransducingCell Cycle ProteinsCheckpoint Kinase 2DeoxyribonucleotidesHydroxyureaLCD1 protein, S cerevisiaeNucleic Acid Synthesis InhibitorsPhosphoproteinsProtein Serine-Threonine KinasesRAD53 protein, S cerevisiaeRibonucleotide ReductasesSaccharomyces cerevisiae ProteinsSRL4 protein, S cerevisiae

Identifiers

PMID18337697
OpenAlexW2052363995

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.